- “Trinity Biotech’s blood-clot analyzer gets FDA nod” (Reuters)
- “Teva Provides Update on Generic Ortho Tri-Cyclen(R) Lo” (Press release issued by Teva Pharmaceutical Industries, Ltd., Trading Markets)
- “GlaxoSmithKline drug protects against cancer-causing viruses” (Hays Pharma)
- “Good News for Sanofi-Aventis: Heart Drug Multaq Receives FDA Approval” (Seeking Alpha)
- “Mylan: FDA approved generic prostate cancer drug” (Business Week)
- “All Fifty States to Screen Newborns for Cystic Fibrosis by 2010” (Press release issued by the Cystic Fibrosis Foundation, PRNewsWire)
- “BioScrip Selected to Participate in Teva Neuroscience MS Research Study” (Press release issued by BioScrip, Inc. and Teva Neuroscience, Trading Markets)
- “Teva and Antares Get FDA Approval of Needle-Free Injector Product” (Press release issued by Teva Neuroscience and Antares Pharma Inc, Trading Markets)
- “GSK says Cervarix effective against more viruses” (Reuters)
- “Pozen Submits NDA for Vimovo (PN 400)” (Trading Markets)
- “Novartis commits to reducing TB in Tanzania” (PharmacyEurope)
- “XenoPort Reveals Results from a Phase 2 Trial of Arbaclofen Placarbil“(Press release issued by XenoPort, Inc., Trading Markets)
- “King and Pain Therapeutics Announce REMOXY(R) NDA Update” (Press release issued by King and Pain Therapeutics, PRNewsWire)
THE LATEST WORD
Top Industry Stories – July 7, 2009
Posted on July 7th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics